Poblet E, Jimenez F, Godinez JM et al.The immunohistochemical expression of CD34 in human hair follicles: a comparative study with the bulge marker CK15. Clin Exp Dermatol 31:807-812

University of Castilla-La Mancha, Ciudad Real, Castille-La Mancha, Spain
Clinical and Experimental Dermatology (Impact Factor: 1.09). 12/2006; 31(6):807-12. DOI: 10.1111/j.1365-2230.2006.02255.x
Source: PubMed


Anti-CD34 antibodies label the bulge region of mouse hair follicles. However, in human hair follicles, CD34 immunoreactivity is found in the outer root sheath below the bulge zone. The immunohistochemical staining of CD34 in catagen and telogen follicles has not been evaluated.
To characterize the expression of CD34 immunoreactivity at different stages of the hair cycle in human terminal hair follicles, and to compare the immunostaining pattern of CD34 with that of CK15, used here as a marker of the bulge region.
Serial vertical sections of human hair follicles in anagen, catagen and telogen phases were immunostained with anti-CD34 (QBEnd 10) and anti-CK15 (LHK15 and C8/144B) antibodies. Double-labelling immunofluorescence was also performed.
The catagen and telogen follicles studied did not show CD34 immunoreactivity in the outer root sheath. The location of CD34 and CK15 immunoreactivity in anagen follicles reveals a different staining pattern: CD34-positive cells are located in the outer root sheath below the attachment zone of the arrector pili muscle, whereas CK15-positive cells are located in the outer root sheath above the attachment zone of the arrector pili muscle.
Only anagen human hair follicles show CD34 immunoreactivity. CD34 and CK15 recognize different types of cells or cells at different stages of differentiation.

Download full-text


Available from: Ander Izeta,
  • Source
    • "Although Lhx2 expression appears to be mandatory regarding the induction of hair growth from a quiescent telogen state, so far no specific epithelial subpopulation has been linked to it. In wild type, a CD49f expressing progenitor typically found in the basal layer of the epidermis [21], [22] is most predominant, followed by CD34 expressing progenitors that are most abundant at the root sheet level of hair follicles below the bulge region [23], [44], [45], [46], [47] (Fig. 1). In addition, a population highly (++) positive for CD49f can typically be distinguished from a population with intermediate (+) positivity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hair cycling is a prime example of stem cell dependent tissue regeneration and replenishment, and its regulatory mechanisms remain poorly understood. In the present study, we evaluated the effect of a blockage in terminal keratinocytic lineage differentiation in the Foxn1(-/-) nude phenotype on the epithelial progeny. Most notably we found a constitutive upregulation of LIM homeobox protein 2 (Lhx2), a marker gene of epithelial stem cellness indispensible for hair cycle progression. However, histological evidence along with an erratic, acyclic rise of otherwise suppressed CyclinD1 levels along with several key markers of keratinocyte lineage differentiation indicate a frustrated expansion of epithelial stem cell niches in skin. In addition, CD49f/CD34/CD200-based profiling demonstrated highly significant shifts in subpopulations of epithelial progeny. Intriguingly this appeared to include the expansion of Oct4+ stem cells in dermal fractions of skin isolates in the Foxn1 knock-out opposed to wild type. Overall our findings indicate that the Foxn1(-/-) phenotype has a strong impact on epithelial progeny and thus offers a promising model to study maintenance and regulation of stem cell niches within skin not feasible in other in vitro or in vivo models.
    PLoS ONE 05/2013; 8(5):e64223. DOI:10.1371/journal.pone.0064223 · 3.23 Impact Factor
  • Source
    • "). Of note, CD34, a specific marker of mouse bulge stem cells, is underrepresented in human bulge cells (Ohyama et al., 2006; Poblet et al., 2006 ; Dog Human 1.6 1.2 0.8 0.4 0 LHX2 * * 0.3 0.2 0.1 0 LHX2 0.3 0.2 0.1 0 TCF3 0.06 0.04 0.02 0 TCF3 0.1 0.08 0.06 0.04 0.02 0 0.04 0.03 0 0.01 0.02 NFATC1 * 0.04 0.03 0 0.01 0.02 NFATC1 * "
    [Show abstract] [Hide abstract]
    ABSTRACT: The hair follicle bulge has attracted great interest as a stem cell repository. Previous studies have focused on rodent or human bulge stem cells, and our understanding of those in other species is limited. In this study, we attempted to localize and characterize stem cell candidates in canine hair follicles. The canine skin xenografting study located label-retaining cells in the outer root sheath around the insertion point of the arrector pili muscle, where the immunoreactivity of human bulge markers, keratin 15 and follistatin, were detected. Canine bulge cell-enriched keratinocytes up-regulated human bulge biomarkers CD200 and DIO2, and conserved key cell regulators of bulge stem cells, such as SOX9 and LHX2. Importantly, canine bulge-derived keratinocytes were highly proliferative in vitro and, when combined with trichogenic dermal cells, reconstituted pilosebaceous structures as well as the epidermis in vivo. Successful detection of canine specific DNA sequences suggested that the regenerated tissue was of canine origin. In addition, canine specific bulge cell and sebocyte lineage markers were expressed in reconstituted pilosebaceous units, implying the multipotency of canine bulge cells. Our findings demonstrate a unique strategy utilizing canine bulge cells to investigate human stem cell biology and intractable hair disorders that involve the bulge region.
    Journal of Investigative Dermatology 04/2010; 130(8):1988-95. DOI:10.1038/jid.2010.68 · 7.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A case of a 5-year-old child with a rare nevus of a hair follicle is reported. Histologically it was characterized by many hair follicles within the dermis at the same level of maturation. This nevus must be differentiated from other hamartomas of hair follicles and from Becker's nevus.
    American Journal of Dermatopathology 07/1984; 6(3):245-7. DOI:10.1097/00000372-198406030-00008 · 1.39 Impact Factor
Show more

Similar Publications